179 related articles for article (PubMed ID: 26285113)
21. Ten-year trend in sleeping pills use in Switzerland: the CoLaus study.
Abolhassani N; Haba-Rubio J; Heinzer R; Vollenweider P; Marques-Vidal P
Sleep Med; 2019 Dec; 64():56-61. PubMed ID: 31670162
[TBL] [Abstract][Full Text] [Related]
22. Effect of repeated gaboxadol administration on night sleep and next-day performance in healthy elderly subjects.
Mathias S; Zihl J; Steiger A; Lancel M
Neuropsychopharmacology; 2005 Apr; 30(4):833-41. PubMed ID: 15602499
[TBL] [Abstract][Full Text] [Related]
23. Improved insomnia symptoms and sleep-related next-day functioning in patients with comorbid major depressive disorder and insomnia following concomitant zolpidem extended-release 12.5 mg and escitalopram treatment: a randomized controlled trial.
Fava M; Asnis GM; Shrivastava RK; Lydiard B; Bastani B; Sheehan DV; Roth T
J Clin Psychiatry; 2011 Jul; 72(7):914-28. PubMed ID: 21208597
[TBL] [Abstract][Full Text] [Related]
24. Hypnotic drug use in Spain: a cross-sectional study based on a network of community pharmacies. Spanish Group for the Study of Hypnotic Drug Utilization.
Rayón P; Serrano-Castro M; del Barrio H; Alvarez C; Montero D; Madurga M; Palop R; DeAbajo FJ
Ann Pharmacother; 1996 Oct; 30(10):1092-100. PubMed ID: 8893114
[TBL] [Abstract][Full Text] [Related]
25. Requests for hypnotic drugs and placebo response in elderly hospital in-patients.
Bayer AJ; Pathy MS
Postgrad Med J; 1985 Apr; 61(714):317-20. PubMed ID: 4022861
[TBL] [Abstract][Full Text] [Related]
26. Eight weeks of non-nightly use of zolpidem for primary insomnia.
Walsh JK; Roth T; Randazzo A; Erman M; Jamieson A; Scharf M; Schweitzer PK; Ware JC
Sleep; 2000 Dec; 23(8):1087-96. PubMed ID: 11145323
[TBL] [Abstract][Full Text] [Related]
27. Persistent insomnia in chronic hypnotic users presenting to a sleep medical center: a retrospective chart review of 137 consecutive patients.
Krakow B; Ulibarri VA; Romero E
J Nerv Ment Dis; 2010 Oct; 198(10):734-41. PubMed ID: 20921864
[TBL] [Abstract][Full Text] [Related]
28. The Association Between Sleeping Pill Use and Metabolic Syndrome in an Apparently Healthy Population in Japan: JMS-II Cohort Study.
Izumida T; Nakamura Y; Sato Y; Ishikawa S
J Epidemiol; 2022 Mar; 32(3):145-150. PubMed ID: 33162423
[TBL] [Abstract][Full Text] [Related]
29. Esmirtazapine in non-elderly adult patients with primary insomnia: efficacy and safety from a 2-week randomized outpatient trial.
Ivgy-May N; Roth T; Ruwe F; Walsh J
Sleep Med; 2015 Jul; 16(7):831-7. PubMed ID: 26047890
[TBL] [Abstract][Full Text] [Related]
30. An oral hypnotic medication does not improve continuous positive airway pressure compliance in men with obstructive sleep apnea.
Bradshaw DA; Ruff GA; Murphy DP
Chest; 2006 Nov; 130(5):1369-76. PubMed ID: 17099012
[TBL] [Abstract][Full Text] [Related]
31. Psychological treatment for insomnia in the management of long-term hypnotic drug use: a pragmatic randomised controlled trial.
Morgan K; Dixon S; Mathers N; Thompson J; Tomeny M
Br J Gen Pract; 2003 Dec; 53(497):923-8. PubMed ID: 14960215
[TBL] [Abstract][Full Text] [Related]
32. Hormonal responses to exercise after partial sleep deprivation and after a hypnotic drug-induced sleep.
Mougin F; Bourdin H; Simon-Rigaud ML; Nguyen NU; Kantelip JP; Davenne D
J Sports Sci; 2001 Feb; 19(2):89-97. PubMed ID: 11217014
[TBL] [Abstract][Full Text] [Related]
33. [Are z-hypnotics better and safer sleeping pills than benzodiazepines?].
Mellingsaeter TC; Bramness JG; Slørdal L
Tidsskr Nor Laegeforen; 2006 Nov; 126(22):2954-6. PubMed ID: 17117195
[TBL] [Abstract][Full Text] [Related]
34. Sleeping pills without regrets. They've long been the risky quick fixes of sleep medicine. Soon some sleeping pills may be sold as long-term solutions.
Harv Health Lett; 2004 Aug; 29(10):1-3. PubMed ID: 15325984
[No Abstract] [Full Text] [Related]
35. Association between sleep characteristics and antihypertensive treatment in older adults.
Hernández-Aceituno A; Guallar-Castillón P; García-Esquinas E; Rodríguez-Artalejo F; Banegas JR
Geriatr Gerontol Int; 2019 Jun; 19(6):537-540. PubMed ID: 30912276
[TBL] [Abstract][Full Text] [Related]
36. Comparative meta-analysis of pharmacotherapy and behavior therapy for persistent insomnia.
Smith MT; Perlis ML; Park A; Smith MS; Pennington J; Giles DE; Buysse DJ
Am J Psychiatry; 2002 Jan; 159(1):5-11. PubMed ID: 11772681
[TBL] [Abstract][Full Text] [Related]
37. [Recent progress in development of hypnotic drugs].
Yamadera H
Nihon Rinsho; 1998 Feb; 56(2):515-20. PubMed ID: 9503861
[TBL] [Abstract][Full Text] [Related]
38. Individualizing therapy for early, middle-of-the-night and late-night insomnia.
Scharf MB
Int J Clin Pract Suppl; 2001 Jan; (116):20-4. PubMed ID: 11219329
[TBL] [Abstract][Full Text] [Related]
39. Treatment of elderly primary insomnia patients with EVT 201 improves sleep initiation, sleep maintenance, and daytime sleepiness.
Walsh JK; Salkeld L; Knowles LJ; Tasker T; Hunneyball IM
Sleep Med; 2010 Jan; 11(1):23-30. PubMed ID: 19945340
[TBL] [Abstract][Full Text] [Related]
40. Situation and problem of administration methods and the intermission of hypnotics.
Uchimura N; Takeuchi N; Kuwahara H; Nose I; Hashizume Y; Shirakawa S; Ohyama T; Maeda H
Psychiatry Clin Neurosci; 2002 Jun; 56(3):295-6. PubMed ID: 12047602
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
